Viking Therapeutics, Inc. (VKTX) › Total AssetsViking Therapeutics, Inc. (VKTX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2014: $3.04M2015: $15.44M2016: $14.54M2017: $22.12M2018: $302.31M2019: $284.26M2020: $256.50M2021: $210.66M2022: $168.53M2023: $368.49M2024: $908.32M2025: $715.73M$715.73M2014Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$715.73M-21.2%2024$908.32M+146.5%2023$368.49M+118.7%2022$168.53M-20.0%2021$210.66M-17.9%2020$256.50M-9.8%2019$284.26M-6.0%2018$302.31M+1266.6%2017$22.12M+52.2%2016$14.54M-5.9%2015$15.44M+407.3%2014$3.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share